Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
04/2014
04/30/2014EP2723390A2 Serpina1 sirnas: compositions of matter and methods of treatment
04/30/2014CN103764173A Compositions and methods for treating skeletal myopathy
04/30/2014CN103764161A Anti-cancer composition comprising Wnt decoy receptors
04/30/2014CN103757054A Recombinant replication-deficient adenovirus vector equine influenza (EI) genetic engineering vaccine and application thereof
04/30/2014CN103757026A Gene sequence and polypeptide of FGFR2b ectodomain and application thereof
04/30/2014CN103757024A Small RNA (Ribonucleic Acid) for disturbing TLR4 receptor and application thereof
04/30/2014CN103757022A Interfering RNA (ribonucleic acid) molecule and application thereof
04/30/2014CN103757021A Double-chain siRNA molecule of silencing DNMT (Desoxvribose Nucleic Acid Methyltransferases) gene and application of double-chain siRNA molecule
04/30/2014CN103757001A Preparation of cell fine particle-siRNA (small interfering Ribose Nucleic Acid) compound and application of cell fine particle-siRNA compound to treatment of AIDS
04/30/2014CN103755810A Long-acting HIV-1 membrane fusion inhibitor
04/30/2014CN103755805A Human monoclonal antibody with HIV-1 Env specificity
04/30/2014CN103751807A Method for controlling CSBV (Chinese bee Sacbrood Virus) by utilizing RNA interference technology
04/30/2014CN103751806A Application of SIRT1 expression interfering agent in preparation of liver cancer stem cell stemness transcription factor expression inhibiting agent
04/30/2014CN103751805A Application of SIRT1 expression interfering agent in preparation of medicine for inhibiting self renewal of liver cancer stem cell agent
04/30/2014CN103751804A Application of interferon regulatory factor 4 (IRF4) gene in coronary atherosclerotic heart disease
04/30/2014CN103751803A Interferon regulatory factor 9 (IRF9) and application of inhibitor thereof in cerebral apoplexy
04/30/2014CN103751802A Application of porcine BTG2 (B-cell translocation gene-2) gene in anti-PRRS (porcine reproductive and respiratory syndrome) virus
04/30/2014CN103751801A Application of miR-143 gene in non-small-cell lung carcinoma
04/30/2014CN103751783A Function of IRF1 in aortic constriction disease and application of inhibitor thereof
04/30/2014CN103751771A Immunity-inducing agent
04/30/2014CN103751211A Methods and pharmaceutical compositions for healing wounds
04/30/2014CN102898508B Polypeptide for enclosing TGF-beta acceptor or IL-10 acceptor, pharmaceutical composition and application
04/30/2014CN102888401B Inhibitor for inducing pluripotent stem cells, and inducing method and application thereof
04/30/2014CN102805870B Gold nano-spherical shell carrier with procedural gene drug release property and preparation method
04/30/2014CN102786675B Block copolymer and synthesis method thereof, and preparation method of nano particles
04/30/2014CN102764442B Method for preparing nano particles comprising protamine and genetic material
04/29/2014US8710026 MiR 204, miR 211, their anti-miRs, and therapeutic uses of same
04/29/2014US8710025 Modified and stabilized GDF propeptides and uses thereof
04/29/2014US8710023 Antisense modulation of C-reactive protein expression
04/29/2014US8710020 Clusterin antisense therapy for treatment of cancer
04/29/2014US8710015 Tropoelastin derivatives
04/29/2014US8709997 Prevention and treatment of osteoarthritis
04/29/2014US8709995 Method for eliciting an immune response to human telomerase reverse transcriptase
04/29/2014US8709812 Drug comprising as the active ingredient proliferative vector containing survivin promoter
04/29/2014US8709720 Methods and kits for predicting the responsiveness of hepatocellular carcinoma patients to 5-fluorouracil-based combination chemotherapy
04/29/2014US8709448 Anti-infective agents and uses thereof
04/29/2014US8709443 Reovirus for the treatment of cellular proliferative disorders
04/29/2014US8709442 Recombinant negative strand virus RNA expression systems and vaccines
04/29/2014US8709441 TC-83-derived alphavirus vectors, particles and methods
04/29/2014US8709427 Assay for the diagnosis of flaviviral infection using antibodies with high affinity for NS1 protein of flavivirusi in hexameric form
04/29/2014US8709426 Nucleotide sequence coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
04/29/2014US8709397 Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response
04/29/2014CA2408571C Mammalian receptor proteins; related reagents and methods
04/29/2014CA2400485C Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
04/24/2014WO2014063134A1 Methods for inhibiting osteolysis
04/24/2014WO2014062801A1 Production of stable non-polyadenylated rnas
04/24/2014WO2014062691A2 Compositions for modulating c9orf72 expression
04/24/2014WO2014062686A1 Methods for modulating c9orf72 expression
04/24/2014WO2014062566A1 Immunomodulation using spores and pollen grains
04/24/2014WO2014062505A1 Improved reliability of assays using a multi-divot platform and multi-source, multi-cell type clusters
04/24/2014WO2014061735A1 NOVEL HIGH-FUNCTIONING ENZYME HAVING ALTERED HUMAN β-HEXOSAMINIDASE B SUBSTRATE SPECIFICITY, AND HAVING PROTEASE RESISTANCE APPLIED THERETO
04/24/2014WO2014060848A2 Treatment methods using adenovirus
04/24/2014WO2014060580A1 Lxvp-mediated calcineurin inhibition in macrophages
04/24/2014WO2014060109A1 Gene therapy for glycogen storage diseases
04/24/2014WO2014036524A3 Genetically modified msc and therapeutic methods
04/24/2014WO2013049307A3 Enhanced immune memory development by aptamer targeted mtor inhibition of t cells
04/24/2014WO2012106465A3 Methods and compositions for increasing sialic acid production and treating sialic related disease conditions
04/24/2014US20140112896 Methods and compositions for the provision of proteins deficient in lysosomal storage diseases
04/23/2014EP2721157A1 New treatment for muscular dystrophies
04/23/2014CN103740759A Recombinant turkey herpesvirus of expressing H5N1subtype avian influenza virus HA gene
04/23/2014CN103740726A Human CDKL5 (cyclin-dependent kinase-like 5) gene-targeted SiRNA (small interfering ribonucleic acid) and application thereof
04/23/2014CN103740722A shRNA (short hairpin ribonucleic acid) inhibiting retinal pigment epithelium apoptosis and application thereof
04/23/2014CN103740713A Complement antagonists and uses thereof
04/23/2014CN103739712A Factor viii, von willebrand factor or complexes thereof with prolonged in vivo half-life
04/23/2014CN103739697A Recombinant protein for resisting porcine pseudorabies virus reproduction and application thereof
04/23/2014CN103736104A Nano-material based on up-conversion luminescence as well as preparation method and application thereof
04/23/2014CN103736103A Cancer suppressor gene ATOH8 and application of encoding protein thereof
04/23/2014CN103736102A Small RNA used for psoriasis treatment, and derivatives and medicinal preparations thereof
04/23/2014CN102807989B Preparation method of recombination live vector vaccines for diseases of canid and/or feline
04/23/2014CN102786695B Amphiphilic triblock copolymer, preparation method and siRNA drug carrier
04/23/2014CN102260322B Antigen peptide of Helicobacter pylori and application thereof
04/23/2014CN102229962B Oncolytic adenovirus vector for modifying and expressing two exogenous genes by fibrin, construction method and application of vector
04/23/2014CN102212108B Determination and application of human RACK1 (receptor for activated C kinase 1) epitope interacting with MKK7 (mitogen-activated protein kinase kinase 7)
04/22/2014US8703908 Expression and export of angiogenesis inhibitors as immunofusins
04/22/2014US8703735 Antisense antiviral compounds and methods for treating a filovirus infection
04/22/2014US8703734 Nanoprobes for detection or modification of molecules
04/22/2014US8703732 Composition for enhancing TRAIL sensitivity comprising inhibitors for expression or activity of TIP41 as a target gene of TRAIL sensitizer
04/22/2014US8703729 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
04/22/2014US8703482 Human artificial chromosome (HAC) vector
04/22/2014US8703153 Salmonella vectored vaccines against Chlamydia and methods of use
04/22/2014US8703142 Methods to bypass CD4+ cells in the induction of an immune response
04/22/2014US8703120 Use of oncolytic herpes viruses for killing cancer stem cells
04/22/2014CA2609234C Anti-il2 antibodies
04/22/2014CA2548135C Synthetic hla binding peptide analogues and uses thereof
04/22/2014CA2546287C Reduction of dermal scarring
04/22/2014CA2507125C Ena nucleic acid pharmaceuticals capable of modifying splicing of mrna precursors
04/22/2014CA2469785C Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor
04/22/2014CA2345209C Antisense modulation of integrin .alpha.4 expression
04/17/2014WO2014059356A2 Selective antisense compounds and uses thereof
04/17/2014WO2014059353A2 Oligomeric compounds comprising bicyclic nucleosides and uses thereof
04/17/2014WO2014059341A2 Antisense compounds and uses thereof
04/17/2014WO2014059326A2 Methods of identifying compounds for treating depression and other related diseases
04/17/2014WO2014059269A2 Multilayer compositions, coated devices and use thereof
04/17/2014WO2014059248A1 Mir-155 enhancement of cd8+ t cell immunity
04/17/2014WO2014059196A2 Diagnosis and treatment of sma and smn deficiency
04/17/2014WO2014059183A2 Methods and automated systems for testing, optimization, and analysis that preserve continuity in identities and status of users who access remote information from different contexts
04/17/2014WO2014059115A1 Compositions and methods for diagnosis and treatment of neurological disease
04/17/2014WO2014059034A2 Nad biosynthesis and precursors for the treatment and prevention of cancer and proliferation
04/17/2014WO2014059031A2 Nad biosynthesis and precursors in the prevention and treatment of inflammation
04/17/2014WO2014058866A2 Treatment of amyotrophic lateral sclerosis
1 ... 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 ... 870